Transgenic Leishmania major and Leishmania donovani axenic promastigotes constitutively expressing mCherry were used for in vitro antileishmanial drug screening. This method requires minimal sample manipulation and can be easily adapted to automatic drug tests, allowing primary high-throughput screenings without the need for expensive and sophisticated instrumentsFil: Vacchina, Paola. University Of Notre Dame-Indiana; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Miguel A. Morales. University Of Notre Dame-Indiana; Estados Unido
International audienceEfforts for the development of new therapeutics, essential for the control of ...
Abstract. Classic techniques for detecting the susceptibility of Leishmania to different drugs are t...
<div><p>Leishmaniasis is a tropical disease threatening 350 million people from endemic regions. The...
Transgenic Leishmania major and Leishmania donovani axenic promastigotes constitutively expressing m...
Transgenic Leishmania major and Leishmania donovani axenic promastigotes constitutively expressing m...
Currently available primary screens for the selection of candidate antileishmanial compounds are not...
Leishmania is the causative agent of leishmaniasis, a neglected tropical disease that affects more t...
Background: Leishmania major cutaneous leishmaniasis is an infectious zoonotic disease. It is produc...
The protozoan parasite Leishmania donovani is the causative agent of visceral leishmaniasis, a disea...
Visceral leishmaniasis is an important parasitic disease of the developing world with a limited arse...
Visceral leishmaniasis is an important parasitic disease of the developing world with a limited arse...
Visceral leishmaniasis is an important parasitic disease of the developing world with a limited arse...
Gene reporter-fluorescent cells have emerged as alternative method for drug screening. Achievement o...
International audienceThe limited success of recent phenotypic anti-leishmanial drug screening campa...
Critical to the search for new anti-leishmanial drugs is the availability of high-throughput screeni...
International audienceEfforts for the development of new therapeutics, essential for the control of ...
Abstract. Classic techniques for detecting the susceptibility of Leishmania to different drugs are t...
<div><p>Leishmaniasis is a tropical disease threatening 350 million people from endemic regions. The...
Transgenic Leishmania major and Leishmania donovani axenic promastigotes constitutively expressing m...
Transgenic Leishmania major and Leishmania donovani axenic promastigotes constitutively expressing m...
Currently available primary screens for the selection of candidate antileishmanial compounds are not...
Leishmania is the causative agent of leishmaniasis, a neglected tropical disease that affects more t...
Background: Leishmania major cutaneous leishmaniasis is an infectious zoonotic disease. It is produc...
The protozoan parasite Leishmania donovani is the causative agent of visceral leishmaniasis, a disea...
Visceral leishmaniasis is an important parasitic disease of the developing world with a limited arse...
Visceral leishmaniasis is an important parasitic disease of the developing world with a limited arse...
Visceral leishmaniasis is an important parasitic disease of the developing world with a limited arse...
Gene reporter-fluorescent cells have emerged as alternative method for drug screening. Achievement o...
International audienceThe limited success of recent phenotypic anti-leishmanial drug screening campa...
Critical to the search for new anti-leishmanial drugs is the availability of high-throughput screeni...
International audienceEfforts for the development of new therapeutics, essential for the control of ...
Abstract. Classic techniques for detecting the susceptibility of Leishmania to different drugs are t...
<div><p>Leishmaniasis is a tropical disease threatening 350 million people from endemic regions. The...